These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11319303)

  • 1. Use of corticosteroid therapy in autoimmune hepatitis resulting in the resolution of cirrhosis.
    Wanless IR
    J Clin Gastroenterol; 2001; 32(5):371-2. PubMed ID: 11319303
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy.
    Cotler SJ; Jakate S; Jensen DM
    J Clin Gastroenterol; 2001; 32(5):428-30. PubMed ID: 11319316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histological regression of liver fibrosis with immunosuppressive therapy in autoimmune hepatitis].
    Valera JM; Smok G; Márquez S; Poniachik J; Brahm J
    Gastroenterol Hepatol; 2011 Jan; 34(1):10-5. PubMed ID: 21194803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis.
    Ustundag G; Kuloglu Z; Kirsaçlioğlu CT; Kansu A; Erden E; Girgin N
    Pediatr Int; 2008 Oct; 50(5):711-3. PubMed ID: 19261129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cryoglobulinemic syndrome and autoimmune hepatitis].
    Callejas JL; García-Núñez E; Fernández-Machín P; Fernández-Moyano A
    Med Clin (Barc); 2002 Oct; 119(14):559. PubMed ID: 12421532
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic hepatitis C/autoimmune hepatitis overlap syndrome: report of two cases].
    Vella FS; Simone B; Orlando P; Simone O; Antonaci S
    Recenti Prog Med; 2004 Oct; 95(10):472-5. PubMed ID: 15560294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate diagnostic criteria for fulminant autoimmune hepatitis.
    Fujiwara K; Yasui S; Yokosuka O
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1230-1. PubMed ID: 26327503
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune hepatitis in the course of chronic HAV--four year observation.
    Woźniakowska-Gesicka T; Kupś J; Wiśniewska-Ligier M; Wróblewska W; Sułat-Syncerek D; al-Batool K
    Med Sci Monit; 2001 May; 7 Suppl 1():207-11. PubMed ID: 12211721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of liver cirrhosis in autoimmune hepatitis.
    Shah AM; Malhotra A; Kothari S; Baddoura W; Depasquale J; Spira R
    Hepatogastroenterology; 2011; 58(112):2115-7. PubMed ID: 22234080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corticosteroid-induced mediastinal lipomatosis in a patient with overlap syndrome (autoimmune hepatitis-primary biliary cirrhosis)].
    Campos-Franco J; Martínez-De Alegría A; Alende-Sixto R; Gonzalez-Quintela A
    Gastroenterol Hepatol; 2011; 34(7):513-4. PubMed ID: 21636175
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined prednisone and levothyroxine improve treatment of severe thrombocytopenia in hepatitis B with compensatory cirrhosis accompanied by subclinical and overt hypothyroidism.
    Xue J; Feng R; Fu H; Jiang Q; Jiang H; Lu J; Liu H; Wang J; Niu T; Wang X; Xie Y; Wang H; Xu L; Liu K; Huang X; Zhang X
    Sci China Life Sci; 2018 Aug; 61(8):924-933. PubMed ID: 29524121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New predictive factors of poor response to therapy in autoimmune hepatitis: role of mean platelet volume.
    Abdel-Razik A; Mousa N; Zakaria S; Elhelaly R; Elzehery R; Zalata K; Awad M; Eldeeb AA; Abdelsalam M
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1373-1379. PubMed ID: 29035910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.
    Czaja AJ
    Aliment Pharmacol Ther; 2014 Feb; 39(4):385-406. PubMed ID: 24387318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical problem-solving. An intricate interplay.
    Moseley RH; Manoogian B; Shehab T; Saint S
    N Engl J Med; 2012 Oct; 367(14):1342-7. PubMed ID: 23034023
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune hepatitis: Unveiling faces.
    Zhu JY; Han Y
    J Dig Dis; 2015 Sep; 16(9):483-8. PubMed ID: 26332151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
    Mendizabal M; Marciano S; Videla MG; Anders M; Zerega A; Balderramo DC; Tisi Baña MR; Barrabino M; Gil O; Mastai R; Yantorno S; Gadano A; Silva MO
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):644-8. PubMed ID: 25923939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis. Making sense of all those antibodies.
    Luxon BA
    Postgrad Med; 2003 Jul; 114(1):79-82, 85-8. PubMed ID: 12875057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Vallone TM; Ditelberg J; Kaplan MM
    Dig Dis Sci; 2005 Jan; 50(1):167-70. PubMed ID: 15712656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
    Golovanova EV; Khomeriki SG; Petrakov AV; Serova TI
    Eksp Klin Gastroenterol; 2010; (8):113-7. PubMed ID: 21268335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.